These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 17562516)

  • 1. Ultrasound evaluation of fetal chromosome disorders.
    Tamsel S; Ozbek S; Demirpolat G
    Diagn Interv Radiol; 2007 Jun; 13(2):97-100. PubMed ID: 17562516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasonographic markers for chromosomal abnormalities in women with negative nuchal translucency and second trimester maternal serum biochemistry.
    Verdin SM; Whitlow BJ; Lazanakis M; Kadir RA; Chatzipapas I; Economides DL
    Ultrasound Obstet Gynecol; 2000 Oct; 16(5):402-6. PubMed ID: 11169322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuchal translucency as a screening test for chromosomal abnormalities in a routine first trimester ultrasound examination.
    Josefsson A; Molander E; Selbing A
    Acta Obstet Gynecol Scand; 1998 May; 77(5):497-9. PubMed ID: 9654169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ultrasound screening for Down syndrome and other chromosomal abnormalities by fetal nuchal translucency measurement between 11-14 weeks of gestation].
    Dimitrova V; Markov D; Chernev T; Karag'ozova Zh; Mazneĭkova V; Andonova S; Vŭzharova R
    Akush Ginekol (Sofiia); 2005; 44(1):32-7. PubMed ID: 15853009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Increased nuchal translucency and cystic hygroma in the first trimester: prenatal diagnosis and neonatal outcome].
    Ducarme G; Graesslin O; Alanio E; Bige V; Gaillard D; Gabriel R
    Gynecol Obstet Fertil; 2005 Oct; 33(10):750-4. PubMed ID: 16139544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sonographic first trimester screening in Switzerland].
    Lapaire O; Sartorius G; Holzgreve W; Tercanli S
    Praxis (Bern 1994); 2005 Feb; 94(6):199-204. PubMed ID: 15754531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Screening for fetal chromosome aberrations. Ultrasonic measurement of nuchal translucency thickness is most efficient].
    Valentin L
    Lakartidningen; 1997 Aug; 94(34):2810-2, 2815-6. PubMed ID: 9303990
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of first-trimester screening by fetal nuchal translucency and maternal age.
    Theodoropoulos P; Lolis D; Papageorgiou C; Papaioannou S; Plachouras N; Makrydimas G
    Prenat Diagn; 1998 Feb; 18(2):133-7. PubMed ID: 9516014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuchal translucency as an important ultrasound screening tool for the early diagnosis of first trimester chromosomal abnormalities. A preliminary experience.
    Borrelli AL; Borrelli P; Felicetti M; Di Domenico A; Laboccetta A; Torella M
    Minerva Ginecol; 2004 Apr; 56(2):179-80. PubMed ID: 15258549
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening for chromosomal abnormalities in an unselected population by fetal nuchal translucency.
    Hafner E; Schuchter K; Philipp K
    Ultrasound Obstet Gynecol; 1995 Nov; 6(5):330-3. PubMed ID: 8590203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between two- and three-dimensional ultrasound measurements of nuchal translucency.
    Clementschitsch G; Hasenöhrl G; Schaffer H; Steiner H
    Ultrasound Obstet Gynecol; 2001 Nov; 18(5):475-80. PubMed ID: 11844167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuchal translucency screening for chromosomal abnormalities in a routine ultrasound practice.
    Frohlich EP
    Prenat Diagn; 1997 Aug; 17(8):785-8. PubMed ID: 9267907
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pregnancy outcome in 1,252 fetuses after nuchal translucency measurement in the 1st trimester].
    Horner E; Holzgreve W; Batucan C; Tercanli S
    Praxis (Bern 1994); 2002 Feb; 91(7):261-5. PubMed ID: 11883361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semiautomated ultrasonographic measurement of fetal nuchal translucency using a computer software tool.
    Bernardino F; Cardoso R; Montenegro N; Bernardes J; de Sá JM
    Ultrasound Med Biol; 1998 Jan; 24(1):51-4. PubMed ID: 9483771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-trimester ultrasonographic screening for trisomy 21 using fetal nuchal translucency and nasal bone.
    Sepulveda W; Wong AE; Dezerega V
    Obstet Gynecol; 2007 May; 109(5):1040-5. PubMed ID: 17470580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pregnancy outcome in fetuses with increased nuchal translucency thickness at 10-14 weeks of pregnancy].
    Maymon R; Dreazen E; Tovbin Y; Weinraub Z; Herman A
    Harefuah; 1999 Jun; 136(11):851-5, 916, 915. PubMed ID: 10955127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for Down's syndrome by fetal nuchal translucency measurement in a high-risk population.
    Pajkrt E; Mol BW; van Lith JM; Bleker OP; Bilardo CM
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):156-62. PubMed ID: 9793186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The application of three-dimensional ultrasound to nuchal translucency measurement in early pregnancy (10-14 weeks): a preliminary study.
    Chung BL; Kim HJ; Lee KH
    Ultrasound Obstet Gynecol; 2000 Feb; 15(2):122-5. PubMed ID: 10775994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation between increased fetal nuchal translucency thickness and chromosomal defects.
    Kagan KO; Avgidou K; Molina FS; Gajewska K; Nicolaides KH
    Obstet Gynecol; 2006 Jan; 107(1):6-10. PubMed ID: 16394033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nuchal translucency: screening for chromosomal abnormalities and congenital malformations. Multicenter study].
    Jemmali M; Valat AS; Poulain P; Favre R; Bourgeot P; Subtil D; Puech F
    J Gynecol Obstet Biol Reprod (Paris); 1999 Oct; 28(6):538-43. PubMed ID: 10598347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.